Project Grant R00HL157687
Award Date
12/9/24
Completion Date
11/30/27
Dollars Obligated
$498K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
University City, MO 63130, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), funded under the Cardiovascular Diseases Research program (CFDA 93.837), will support a $198,936 research project conducted by New York University School of Medicine. The project aims to investigate the impact of restrictive drug coverage policies, such as cost-sharing and prior authorization requirements, on prescribing patterns, medication adherence, and clinical outcomes for patients with heart failure with...
This $626,609 project grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to evaluate a community-to-facility integrated strategy for implementing the World Health Organization's HEARTS-D module to improve diabetes care and outcomes in urban Bangladesh. The key activities involve: 1) Developing and optimizing the implementation strategy through mixed methods assessments, implementation mapping, and iterative...
This Project Grant award of $194,400 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), supports the development of a multilevel implementation intervention to equitably prescribe evidence-based therapy for hospitalized heart failure patients. The key products or services to be delivered through this funding include: Assessing multilevel variation in equitable guideline-directed medical therapy (GDMT) prescribing during...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,321,108 Project Grant under CFDA 93.837 (Cardiovascular Diseases Research) to New York University School of Medicine to conduct transdisciplinary implementation research on a strategy called PT4A. PT4A integrates peer-based medication delivery, peer coaching, and health information technology to improve medication adherence and reduce blood pressure among patients with uncontrolled hypertension in Western Kenya. The study aims to...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), is funding a randomized controlled trial to evaluate the effectiveness of gamification and social incentives in increasing adherence to physical activity recommendations among patients with heart failure with preserved ejection fraction (HFPEF). The 5-year, $809,029 award will support a 3-arm trial to assess whether interventions using...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $708,678 to Wake Forest University Health Sciences to conduct a Sequential Multiple Assignment Randomized Trial (SMART) study. The study aims to determine the most effective interventions to reduce food insecurity and improve adherence to hypertension treatments in patients with uncontrolled hypertension. The interventions being...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $321,363 to Nucleusrx, Inc. to develop and test a virtual care platform and remote intervention tool targeting post-acute care heart failure (HF) patients. The goal is to create a solution that enables healthcare providers to implement a safe discharge transition plan from hospital to home, while allowing rapid optimization of...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will fund the implementation and pilot-testing of an integrated sickle-cell screening and violence prevention program in antenatal care settings in India. The $167,560 award to the Trustees of Boston University, Massachusetts will be used to: 1) conduct formative research to inform the adaptation of the Jamii Bora intervention, 2) adapt the...
This $590,371 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to identify successful strategies for implementing specialist palliative care for people with advanced heart failure. The grant will fund a rigorous multisite, mixed methods study within the Department of Veterans Affairs (VA) healthcare system to evaluate associations between palliative care and cardiology program structures/processes and the reach of...
The National Heart, Lung, and Blood Institute (NHLBI) has awarded a $648,073 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to The Johns Hopkins University to conduct the ADHINCRA study, which aims to address hypertension care in Ghana and Nigeria. The project will implement a multilevel intervention that integrates home-based blood pressure monitoring, team-based care with nurse training, and simplified hypertension treatment protocols to improve blood pressure control in...